🌐 Entity

Tirzepatide

Anti-diabetic and weight loss medication

📊 Rating

3 news mentions · 👍 0 likes · 👎 0 dislikes

📌 Topics

Pharmaceutical innovation (2)
Health risks (1)
Online medication safety (1)
Eating disorders (1)
Regulatory oversight (1)
Treatment efficacy (1)
Market impact (1)
Combination therapy (1)
Chronic disease treatment (1)

🏷️ Keywords

Taltz (2) · Zepbound (2) · Psoriasis (2) · Eli Lilly (2) · Combination therapy (2) · weight-loss injections (1) · eating disorders (1) · online medication (1) · NHS regulation (1) · Saxenda (1) · Mounjaro (1) · Wegovy (1) · body image (1) · Clinical trial (1) · Biologic treatment (1) · Pharmaceutical economy (1) · Weight loss (1) · Clinical study (1) · Pharmaceutical innovation (1)

📖 Key Information

Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin). In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.

📰 Related News (3)

🇬🇧 'I thought I was going to die' - Woman calls for tighter weight-loss jabs checks (2026-02-23)
Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online....
🇺🇸 Lilly’s taltz and zepbound combination shows superior efficacy in psoriasis (2026-02-18)
🇺🇸 Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study (2026-02-18)
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage st...

🔗 Entity Intersection Graph

People and organizations frequently mentioned alongside Tirzepatide:

Psoriasis · 2 shared articles
Eli Lilly · 2 shared articles
🌐
Ixekizumab · 2 shared articles
🌐
Combination therapy · 1 shared articles
Liraglutide · 1 shared articles
Semaglutide · 1 shared articles
Weight loss · 1 shared articles